3

OWNERSHIP DOCUMENT

Company: BRAINSTORM CELL THERAPEUTICS INC.
Filed: March 6, 2017
Period of Report: March 6, 2017
Accession Number: 0001144204-17-012939

View Document ↗ View on SEC.gov ↗